当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析

金域医学

(603882)

  

流通市值:125.62亿  总市值:126.47亿
流通股本:4.60亿   总股本:4.63亿

金域医学(603882)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.48亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益648300.91万元,未分配利润447411.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产920040.77万元,负债271739.86万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,350,977,738.086,030,452,713.414,538,151,376.332,996,929,115.16
营业总成本1,292,025,224.525,814,342,183.774,282,602,888.452,850,900,501.38
其他经营收益
营业利润66,269,455.61-129,870,790.27-63,006,298.9-106,098,268.05
利润总额61,072,831.86-181,611,034.17-82,117,770.48-109,608,128.07
净利润47,882,754.88-178,600,830.71-88,794,076.93-96,868,140.52
每股收益
其他综合收益-15,756,437.56-13,554,392.73-8,139,141.33-8,271,686.13
综合收益总额32,126,317.32-192,155,223.44-96,933,218.26-105,139,826.65
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,187,258,989.576,613,006,609.826,727,870,048.766,704,565,580.68
非流动资产:
非流动资产合计3,013,148,731.242,991,523,715.482,986,035,762.083,078,939,700.78
资产总计9,200,407,720.819,604,530,325.39,713,905,810.849,783,505,281.46
流动负债:
流动负债合计1,977,975,797.232,042,154,195.912,141,899,809.272,172,694,707.23
非流动负债:
非流动负债合计739,422,800.64703,826,041.81618,233,908.77662,745,089.81
负债合计2,717,398,597.872,745,980,237.722,760,133,718.042,835,439,797.04
所有者权益(或股东权益):
归属于母公司股东权益合计6,348,753,585.956,729,386,755.736,828,436,021.66,824,524,149.74
股东权益合计6,483,009,122.946,858,550,087.586,953,772,092.86,948,065,484.42
负债和股东权益合计9,200,407,720.819,604,530,325.39,713,905,810.849,783,505,281.46
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,354,749,024.946,976,591,310.024,973,686,069.043,213,753,855.16
经营活动现金流出小计1,311,319,338.895,774,582,042.924,301,778,174.562,863,284,363.71
经营活动产生的现金流量净额43,429,686.051,202,009,267.1671,907,894.48350,469,491.45
投资活动产生的现金流量:
投资活动现金流入小计6,771,560.4499,433,636.2169,898,072.0313,242,741.86
投资活动现金流出小计143,101,126.21470,405,734.18332,678,444.24212,570,270.83
投资活动产生的现金流量净额-136,329,565.77-370,972,097.97-262,780,372.21-199,327,528.97
筹资活动产生的现金流量:
筹资活动现金流入小计15,908,533.58221,894,530.96113,745,121.5583,745,121.55
筹资活动现金流出小计427,512,219.91616,097,235.12507,482,770.74485,104,003.43
筹资活动产生的现金流量净额-411,603,686.33-394,202,704.16-393,737,649.19-401,358,881.88
汇率变动对现金及现金等价物的影响11,117,107.32-13,551,197.53-6,458,287.49-7,028,422.73
现金及现金等价物净增加额-493,386,458.73423,283,267.448,931,585.59-257,245,342.13
期末现金及现金等价物余额2,352,420,648.982,845,807,817.062,431,456,135.212,165,279,207.49
补充资料:
现金及现金等价物的净增加额-423,283,267.44--257,245,342.13
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
信达证券唐爱金0.811.051.312026-04-29
中金公司张琎,陈诗雨0.901.03--2026-04-28
中国银河孟熙,程培1.101.311.512026-04-25
TOP↑